Sakamoto et al., 1997 - Google Patents
Difference of virus populations in HIV carriers in relation to AZT treatment.Sakamoto et al., 1997
- Document ID
- 4563029728446098648
- Author
- Sakamoto T
- Wakamiya N
- Tochikura A
- Tsuchie H
- Kurimura T
- Sakamoto T
- Wakamiya N
- Tochikura A
- Tsuchie H
- Kurimura T
- Publication year
- Publication venue
- International journal of STD & AIDS
External Links
Snippet
To analyse the appearance of AZT-resistant HIV in HIV carriers after AZT treatment and compare the mutations responsible for resistance employing cloned HIV DNA derived from provirus and free virions in plasma, serial blood specimens were taken before and after AZT …
- 229960002555 Zidovudine 0 title abstract description 71
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kozal et al. | A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients | |
| Wainberg et al. | Development of HIV-1 resistance to (−) 2′-deoxy-3′-thiacytidine in patients with AIDS or advanced AIDS-related complex | |
| Gao et al. | In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2', 3'-dideoxyinosine | |
| Lessells et al. | Are subtype differences important in HIV drug resistance? | |
| US7078516B1 (en) | Nucleotide sequences derived from the genome of retroviruses of the hiv-1, hiv-2 and siv type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses | |
| Mayers et al. | Characterization of HIV isolates arising after prolonged zidovudine therapy | |
| St. Clair et al. | Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase | |
| Kellam et al. | Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance | |
| Peeters et al. | Predominance of subtype A and G HIV type 1 in Nigeria, with geographical differences in their distribution | |
| USRE37918E1 (en) | Nucleic acid derivatives | |
| Toure-Kane et al. | Sequence Note: Identification of All HIV Type 1 Group M Subtypes in Senegal, a Country with Low and Stable Seroprevalence | |
| Yusa et al. | HIV-1 acquires resistance to two classes of antiviral drugs through homologous recombination | |
| Balotta et al. | Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals | |
| NERURKAR et al. | Sequence Note: HIV Type 1 Subtype E in Commercial Sex Workers and Injection Drug Users in Southern Vietnam | |
| Wainberg et al. | Clinical correlates and molecular basis of HIV drug resistance | |
| Palmer et al. | Tenofovir, adefovir, and zidovudine susceptibilities of primary human immunodeficiency virus type 1 isolates with non-B subtypes or nucleoside resistance | |
| US6531588B1 (en) | Methods for HIV sequencing and genotyping | |
| Kuritzkes et al. | Emergence of dual resistance to zidovudine and lamivudine in HIV-1-infected patients treated with zidovudine plus lamivudine as initial therapy | |
| Diaz et al. | Divergence of HIV-1 quasispecies in an epidemiologic cluster | |
| Günthard et al. | Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol | |
| Murphy et al. | Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: An age–cohort effect for HTLV-II RFLP type a0 | |
| Gurusinghe et al. | Reverse transcriptase mutations in sequential HIV‐1 isolates in a patient with AIDS | |
| Reichman et al. | Didanosine (ddI) and zidovudine (ZDV) susceptibilities of human immunodeficiency virus (HIV) isolates from long-term recipients of ddI | |
| Cilla et al. | Molecular evidence of homosexual transmission of HIV type 2 in Spain | |
| Sakamoto et al. | Difference of virus populations in HIV carriers in relation to AZT treatment. |